SlideShare une entreprise Scribd logo
1  sur  79
Lecture 13 Glycolysis
Catabolism 
Catabolism is the set of metabolic 
pathways that breaks down molecules 
into smaller units to release energy
Central Role of Glucose 
Major pathways of glucose utilization
Glycolysis 
– Carried out by nearly every living cell 
• In cytosol of eukaryotes 
– Catabolic process 
• Releases energy stored in covalent bonds 
– Stepwise degradation 
• Glucose 
• Other simple sugars
Overview of glycolysis
Two phases of glycolysis 
Glucose + 6O2 = 6CO2 + 6H2O DGo= -2840 kJ/mol 
Glucose + 2NAD+ = 2Pyruvate + 2NADH + 2H+ DGo = -146 kJ/mol 
5.2% of total free energy that can be released by glucose is released in 
glycolysis.
Reaction 1: phosphorylation 
Phosphorylation of glucose 
Glycolysis takes place in the cytosol of cells. 
Glucose enters the Glycolysis pathway by conversion to glucose-6-phosphate. 
Initially there is energy input corresponding to cleavage of two ~P bonds of ATP. 
Kinase: An enzyme that catalyzes the phosphorylation of a molecule using ATP.
Glycolysis - Enzyme mechanisms 
Pictorial analogy: water represents flux of metabolites, amount of water in flask 
represents amount of a particular intermediate, pipes between flasks are enzymes, vertical 
drop represents decrease in free energy 
DG˚ = height difference between flask bottoms (The change in standard Gibbs free energy, 
the formation of 1 mole substance) 
DG = height difference between water levels (The change in Gibbs free energy ) 
Koelle, lec15, p21
Hexokinase catalyzes: 
Glucose + ATP  glucose-6-P + ADP 
The reaction involves nucleophilic attack of the C6 
hydroxyl O of glucose on P of the terminal phosphate 
of ATP. 
ATP binds to the enzyme as a complex with Mg++. 
N 
N 
NH2 
N N 
O 
CH2 
H H 
H 
OH OH 
H 
O 
O O 
-O P O P O P O 
O- O- 
O- 
adenine 
ribose 
ATP 
adenosine triphosphate
Induced fit: 
Glucose binding 
to Hexokinase 
stabilizes a 
conformation 
in which: 
 the C6 hydroxyl of the 
bound glucose is close to 
the terminal phosphate of 
ATP, promoting catalysis. 
 water is excluded from the active site. 
This prevents the enzyme from catalyzing ATP 
hydrolysis, rather than transfer of phosphate to glucose.
Hexokinase reaction 
I. This enzyme is present in most cells. In liver Glucokinase 
is the main hexokinase which prefers glucose as 
substrate. 
II. It requires Mg-ATP complex as substrate. Un-complexed 
ATP is a potent competitive inhibitor of this enzyme. 
III. Enzyme catalyses the reaction by proximity effect; 
bringing the two substrate in close proximity. 
IV. This enzyme undergoes large conformational change upon 
binding with Glucose. It is inhibited allosterically by G6P.
Reaction 2: isomerization 
Conversion of glucose 6-phosphate to fructose 6-phosphate 
aldose ketose 
Isomerase: An enzyme that catalyzes the transformation of compounds into 
their positional isomers. In the case of sugars this usually involves the 
interconversion of an aldose into a ketose, or vice versa.
Phosphoglucose Isomerase catalyzes: 
glucose-6-P (aldose)  fructose-6-P (ketose) 
The mechanism involves acid/base catalysis. 
The acid/base catalysis, and is thought to proceed via an enediol intermediate, as with 
Phosphoglucose Isomerase. 
Active site Glu and His residues are thought to extract and donate protons during catalysis.
Reaction 3: phosphorylation
CH2OPO3 
2- 
Phosphofructokinase 
6 
1 CH2OPO3 
CH2OH 
2 
OH 
5 
H 
O 
H HO 
4 3 
OH H 
6 
2- 
CH2OPO3 
2 
OH 
2- 
5 
H 
O 
H HO 
4 3 
OH H 
1 
ATP ADP 
Mg2+ 
fructose-6-phosphate fructose-1,6-bisphosphate 
Phosphofructokinase catalyzes: 
fructose-6-P + ATP  fructose-1,6-bisP + ADP 
This highly spontaneous reaction has a mechanism similar 
to that of Hexokinase. 
The Phosphofructokinase reaction is the rate-limiting step 
of Glycolysis. 
The enzyme is highly regulated.
Phosphofructokinase-1 Reaction: Transfer of 
phosphoryl group from ATP to C-1 of 
F6P to produce Fructose 1,6 bisphosphate. 
I. This step is an important irreversible, regulatory step. 
II. The enzyme Phosphofructokinase-1 is one of the most complex 
regulatory enzymes, with various allosteric inhibitors and 
activators. 
III. ATP is an allosteric inhibitor, and Fructose 2,6 bisphosphate 
is an activator of this enzyme. 
IV. ADP and AMP also activate PFK-1 whereas citrate is an 
inhibitor.
Reaction 4: cleavage
1CH2OPO3 
2 
HO 3 
H 
H OH 
H OH 
C 
C 
C 
C 
CH2OPO3 
4 
5 
6 
2- 
Aldolase 
2- 
O 
3 
2 
1 
CH2OPO3 
2- 
C 
O 
CH2OH 
H O 
C 
C 
CH2OPO3 
1 
2 
3 
+ H OH 
fructose-1,6- 
bisphosphate 
dihydroxyacetone glyceraldehyde-3- 
phosphate phosphate 
Triosephosphate Isomerase 
Aldolase catalyzes: fructose-1,6-bisphosphate  
2- 
dihydroxyacetone-P + glyceraldehyde-3-P 
The reaction is an aldol cleavage, the reverse of an aldol condensation. 
Note that C atoms are renumbered in products of Aldolase.
Schiff base intermediate of 
Aldolase reaction 
lysine 
A lysine residue at the active site functions in catalysis. 
The keto group of fructose-1,6-bisphosphate reacts with the e- 
amino group of the active site lysine, to form a protonated 
intermediate. 
Cleavage of the bond between C3 & C4 follows.
Reaction 5: isomerization 
Triose Phosphate Isomerase (TIM) catalyzes: 
dihydroxyacetone-P  glyceraldehyde-3-P
Triose Phosphate Isomerase (TPI) 
Triose phosphate isomerase (TPI) 
-> Isomerisation accelerated 1010-fold 
-> Kcat/Km = 2*108 M-1 s-1 -> kinetically 
perfect enzyme 
-> suppresses an undesired side reaction 
Reaction 100 times faster 
TPI traps enediol intermediate -> prevents side 
reaction -> opens again when GAP formed
Reaction 6: oxidation 
Glyceraldehyde-3-phosphate Dehydrogenase catalyzes: 
glyceraldehyde-3-P + NAD+ + Pi  
1,3-bisphosphoglycerate + NADH + H+
Covalent catalysis
Reaction 7: substrate level phosphorylation 
Phosphoglycerate Kinase catalyzes: 
1,3-bisphosphoglycerate + ADP  3-phosphoglycerate + ATP 
This phosphate transfer is reversible.
Reaction 8: shift of phosphoryl group 
Phosphoglycerate Mutase catalyzes: 
3-phosphoglycerate  2-phosphoglycerate 
Mutase: An enzyme that catalyzes the transposition of functional groups, 
such as phosphates, sulfates, etc.
An active site histidine 
side-chain participates in 
Pi transfer, by donating & 
accepting phosphate. 
The process involves a 
2,3-bisphosphate 
intermediate. 
C 
C 
CH2OPO3 
2- 
O O- 
1 
H OPO3 
2- 
2 
3 
2,3-bisphosphoglycerate
Phosphoglycerate Mutase Reaction: Conversion of 3- 
phosphoglycerate to 2-phosphoglycerate (2-PG). 
I. In active form, the phosphoglycerate mutase is phosphorylated 
at His-179. 
II. There is transfer of the phosphoryl group from enzyme to 3-PG, 
generating enzyme bound 2,3-biphosphoglycerate intermediate. 
This compound has been observed occasionally in reaction 
mixture. 
III. In the last step of reaction the phosphoryl group from the C-3 of 
the intermediate is transferred to the enzyme and 2-PG is 
released. 
IV. In most cells 2,3BPG is present in trace amount, but in 
erythrocytes it is present in significant amount. There it regulates 
oxygen affinity to hemoglobin.
Reaction 9: dehydration 
Enolase catalyzes: 
2-phosphoglycerate  phosphoenolpyruvate + H2O 
This dehydration reaction is Mg++-dependent.
Reaction 10: substrate level phosphorylation 
Pyruvate Kinase catalyzes: 
phosphoenolpyruvate + ADP  pyruvate + ATP
glucose Glycolysis 
ATP 
ADP 
glucose-6-phosphate 
Hexokinase 
Phosphoglucose Isomerase 
fructose-6-phosphate 
ATP 
ADP 
fructose-1,6-bisphosphate 
Phosphofructokinase 
Aldolase 
glyceraldehyde-3-phosphate + dihydroxyacetone-phosphate 
Triosephosphate 
Isomerase 
Glycolysis continued
glyceraldehyde-3-phosphate 
NAD+ + Pi 
NADH + H+ 
Glyceraldehyde-3-phosphate 
Dehydrogenase 
1,3-bisphosphoglycerate 
ADP 
ATP 
3-phosphoglycerate 
Phosphoglycerate Kinase 
Phosphoglycerate Mutase 
2-phosphoglycerate 
H2O 
Enolase 
phosphoenolpyruvate 
ADP 
ATP 
Pyruvate Kinase 
pyruvate 
Glycolysis 
continued.
There are 10 enzyme-catalyzed reactions in glycolysis. 
There are two stages 
Stage 1: (Reactions 1-5) A preparatory stage in which glucose is phosphorylated, 
converted to fructose which is again phosphorylated and cleaved into two 
molecules of glyceraldehyde-3-phosphate. In this phase there is an investment of 
two molecules of ATP. 
Stage 2: (Reactions 6-10) The two molecules of glyceraldehyde-3-phosphate are 
converted to pyruvate with the generation of four ATP molecules and two 
molecules of NADH. Thus there is a net gain of two ATP molecules per molecule of 
Glucose in glycolysis. 
Importance of phosphorylated intermediates: 
1. Possession of negative charge which inhibit their diffusion through membrane. 
2. Conservation of free energy in high energy phosphate bond. 
3. Facilitation of catalysis.
Summary of glycolysis 
-> 10 reaction steps 
-> 1 x C-6 (glucose) converted into 2x C-3 (pyruvate) 
-> oxidation of glucose -> 2 NADH generated 
-> 2 ATPs used + 4 ATPs generated -> pay off: 2 ATPs 
33
Glycolysis - total pathway, omitting H+: 
glucose + 2 NAD+ + 2 ADP + 2 Pi  
2 pyruvate + 2 NADH + 2 ATP 
In aerobic organisms: 
 pyruvate produced in Glycolysis is oxidized to CO2 
via Krebs Cycle (citric acid cycle) 
 NADH produced in Glycolysis & Krebs Cycle is 
reoxidized via the respiratory chain, with production 
of much additional ATP.
Regulation of Glycolysis: 
Two types controls for metabolic reactions: 
a) Substrate limited : When concentrations of reactant and products 
in the cell are near equilibrium, then it is the availability of 
substrate which decides the rate of reaction. 
b) Enzyme-limited: When concentration of substrate and products are 
far away from the equilibrium, then it is activity of enzyme that 
decides the rate of reaction. 
Three steps in glycolysis have enzymes which regulate the flux of 
glycolysis. 
I. The hexokinase (HK) 
II. The phoshofructokinase (PFK) 
III. The pyruvate kinase
The Glycolysis pathway is regulated by control of 3 
enzymes: 
Hexokinase, Phosphofructokinase & Pyruvate Kinase. 
 Local control of metabolism involves regulatory effects 
of varied concentrations of pathway substrates or 
intermediates, to benefit the cell. 
 Global control is for the benefit of the whole organism, 
& often involves hormone-activated signal cascades. 
Liver cells have major roles in metabolism, including 
maintaining blood levels various of nutrients such as 
glucose. Thus global control especially involves liver
DG < 0 
B C 
Rate-limiting steps are 
regulated: 
reactions in the pathway that 
operate away from 
equilibrium are regulated. 
At these reaction 
steps there is a build-up of 
substrates because 
the substrates are not converted to 
products 
fast enough. 
Typically these reactions are 
regulated. 
DG ~ 0 
C D
Hexokinase 
Inhibitors 
Glucose 6-phosphate 
Phosphofructokinase 
Pyruvate kinase 
ATP 
CITRIC ACID CYCLE 
(ATP, citrate) 
ATP, citrate, 
PEP 
Activators 
ADP, AMP, 
Fructose 2,6P 
Regulation of Glycolysis
CITRIC ACID CYCLE
Hexokinase 
Hexokinase: It is allosterically inhibited by its product 
Glucose 6 phosphate. In liver Glucokinase is inhibited 
by Fructose 6 Phosphate. Uncomplexed ATP acts as a 
competitive inhibitor of this enzyme. 
• Hexokinase reaction is metabolically irreversible 
• G6P (product) levels increase when glycolysis is inhibited at 
sites further along in the pathway 
Recall there are 4 isozymes 
• G6P inhibits hexokinase isozymes I, II and III 
• Glucokinase (hexokinase IV) forms G6P in the liver (for 
glycogen synthesis) when glucose is abundant (activity is 
modulated by fructose phosphates and a regulatory protein)
Hexokinase IV 
(glucokinase) 
• Glucokinase translocates 
between the cytoplasm and 
nucleus of liver cells. 
• Glucose enters mammalian cells by passive transport down a concentration 
gradient from blood to cells 
• Glucose uptake into skeletal and heart muscle and adipocytes by GLUT 4 is 
stimulated by insulin 
• Other GLUT transporters mediate glucose transport in and out of cells in the 
absence of insulin 
• GLUT2 is transporter for hepatocytes 
• Regulator protein – inside the nucleus 
– Binds Hexokinase IV and inhibits it 
– Protein has regulatory site 
• Competition between glucose and fructose 6-phosphate 
– Glucose stimulates release of hexokinase IV into cytoplasm 
– Fructose 6-phosphate inhibits this process 
• Hexokinase IV not affected by glucose 6-phosphate as the other isozymes are
 Glucokinase is subject to inhibition by glucokinase 
regulatory protein (GKRP). 
The ratio of Glucokinase to GKRP in liver changes in 
different metabolic states, providing a mechanism for 
modulating glucose phosphorylation. 
 One effect of insulin, a hormone produced when blood 
glucose is high, is activation in liver of transcription of 
the gene that encodes the Glucokinase enzyme. 
 Glucokinase is not subject to product inhibition by 
glucose-6-phosphate. Liver will take up & phosphorylate 
glucose even when liver [glucose-6-phosphate] is high.
Phosphofructokinase-1 (PFK-1): 
It’s activity is controlled by a complex allosteric regulation. 
ATP is the end product of glycolysis as well as it is substrate for PFK. In 
presence of high concentration of ATP, ATP binds to inhibition site of PFK, 
and thereby decreases the activity of enzyme. (allosteric inhibitor) 
AMP, ADP and Fructose 2, 6 biphosphate act as allosteric activators of 
this enzyme. 
Activation of enzyme by AMP overcomes the inhibitory effect of ATP. 
Two other enzymatic activities are involved in the regulation of PFK. 
a) Adnylate kinase: It readily equilibrates 2 ADP molecules to one ATP and 1 
AMP: 2ADP = ATP + AMP Any decrease in ATP and increase in ADP 
results in an increase in AMP concentration, which activates PFK. 
b) Fructose 1,6-bisphosphatase (FBPase): It catalyzes conversion of FBP to 
Fructose 6-phosphate, thus reverting back the PFK reaction.
Regulation of Phosphofructokinase-1 
• Important - this step commits glucose to glycolysis 
• AMP allosterically activates PFK-1 by relieving the ATP inhibition 
(ADP is also an activator in mammalian systems) 
• Changes in AMP and ADP concentrations can control the flux 
through PFK-1 
•AMP relieves ATP inhibition of PFK-1
Pyruvate Kinase: It is allosterically inhibited by ATP. ATP 
binding to the inhibitor site of pyruvate kinase decreases its 
ability to bind phosphoenol pyruvate (PEP) substrate. 
• PK is allosterically activated by Fructose 1,6 BP 
• PK inhibited by accumulation of alanine. 
• It is also inhibited by Acetyl coenzyme A and long chain fatty acid.
Liver form – low blood sugar ®glucagon ® increased cAMP® 
cAMP-dependent protein kinase ® PK inactivation (is reversed by 
protein phosphatase)
Transcriptional regulation of Pyruvate Kinase 
High [glucose] within liver cells causes a 
transcription factor carbohydrate responsive 
element binding protein (ChREBP) to be 
transferred into the nucleus, where it activates 
transcription of the gene for Pyruvate 
Kinase.
Entry points for other sugars into glycolysis 
Uridine diphosphate galactose 
Galactose toxic if transferase is missing 
 All carbohydrates enter glycolysis 
 In muscle, often via hexokinase
Case Study 
A 9-month-old has recurrent bouts of sweating and 
vomiting. Symptoms began shortly after weaning and 
introduction to solid foods. Testing reveals hypoglycemia 
and lactic acidosis after consumption of milk formula or fruit. 
Enzyme activity testing reveals a deficiency in fructose 1- 
phosphate aldolase. 
Notably, her 3-year-old brother has a marked aversion to 
fruit.
Fructose intolerance 
Hereditary fructose intolerance results from a 
defect in fructose breakdown in the liver, usually 
in aldolase.
Galactosemia 
Galatosemia results from a 
defect in galactose breakdown. 
Defects in GALK 
(galactokinase), 
GALT 
(transferase), or 
GALE (epimerase) 
all cause 
galatosemia.
Fate of the products, pyruvate and NADH 
Fig 14- 
3
Fermentation in Animals
Lactate Dehydrogenase 
O- 
C 
C 
CH3 
O 
O 
O- 
C 
HC 
CH3 
OH 
O 
NADH + H+ NAD+ 
pyruvate lactate 
Lactate Dehydrogenase catalyzes reduction of the keto in 
pyruvate to a hydroxyl, yielding lactate, as NADH is oxidized to 
NAD+. 
Skeletal muscles ferment glucose to lactate during exercise, when 
the exertion is brief and intense. 
Lactate released to the blood may be taken up by other tissues, or 
by skeletal muscle after exercise, and converted via Lactate 
Dehydrogenase back to pyruvate, which may be oxidized in Krebs 
Cycle or (in liver) converted to back to glucose via gluconeogenesis
Cell membranes contain carrier proteins that facilitate transport 
of lactate. 
Lactate serves as a fuel source for cardiac muscle as well as 
brain neurons. 
Astrocytes, which surround and protect neurons in the brain, 
ferment glucose to lactate and release it. 
Lactate taken up by adjacent neurons is converted to pyruvate 
that is oxidized via Krebs Cycle.
Fermentation in Yeast
Pyruvate Alcohol 
Decarboxylase Dehydrogenase 
O- 
C 
C 
CH3 
O 
O 
NADH + H+ NAD+ 
H O H 
C OH 
CH3 
C 
CH3 
H 
CO2 
pyruvate acetaldehyde ethanol 
Some anaerobic organisms metabolize pyruvate to 
ethanol, which is excreted as a waste product. 
NADH is converted to NAD+ in the reaction 
catalyzed by Alcohol Dehydrogenase.
Glycolysis, omitting H+: 
glucose + 2 NAD+ + 2 ADP + 2 Pi  2 pyruvate + 2 NADH + 2 ATP 
Fermentation, from glucose to lactate: 
glucose + 2 ADP + 2 Pi  2 lactate + 2 ATP
Regulation of 
glycolysis 
Irreversible steps are 
regulated: 
Hexokinase/Glucokinase 
Phosphofructokinase I 
Pyruvate Kinase
Regulation of glycolysis in the muscle 
-> ATP based regulation 
ATP inhibits all 3 enzymes Need for ATP (high AMP) activates PFK 
61
NADPH is 
necessary to 
protect against 
reactive oxygen 
species 
Ribose 5-P is 
necessary in rapidly 
dividing cells 
Glucose 6-P + 2 NADP+ + H2O  Ribose 5-P + 2 NADPH + 2 H+ + CO2
Regulation 
G6P 
dehydrogenase is 
allosterically 
inhibited by 
NADPH; activated 
by NADP+
Sample questions 
• Glycolytic pathway regulation involves 
• A. allosteric stimulation by ADP 
• B. allosteric inhibition by ATP 
• C. feedback, or product, inhibition by ATP 
• D. all of the above 
• Why does the glycolytic pathway continue in the direction of 
glucose catabolism? 
• A. There are essentially three irreversible reactions that act as 
the driving force for the pathway 
• B. High levels of ATP keep the pathway going in a forward 
direction 
• C. The enzymes of glycolysis only function in one direction 
• D. Glycolysis occurs in either direction
Sample questions 
The released energy obtained by oxidation of glucose is stored as 
A. a concentration gradient across a membrane 
B. ADP 
C. ATP 
D. NAD+ 
A kinase is an enzyme that 
A. removes phosphate groups of substrates 
B. uses ATP to add a phosphate group to the substrate 
C. uses NADH to change the oxidation state of the substrate 
D. removes water from a double bond
Sample questions 
• For every one molecule of sugar glucose which is oxidized 
__________ molecule of pyruvic acid are produced. 
• A.1 
• B.2 
• C.3 
• D.4 
• The enzymes of glycolysis in a eukaryotic cell are located in 
the 
• A.intermembrane space 
• B.plasma membrane 
• C.cytosol 
• D.mitochondrial matrix
Sample questions 
• Which of the following is not true of glycolysis? 
• A.ADP is phosphorylated to ATP via substrate level 
phosphorylation 
• B.The pathway does not require oxygen 
• C.The pathway oxidizes two moles of NADH to NAD+ for each 
mole of glucose that enters 
• D.The pathway requires two moles of ATP to get started 
catabolizing each mole of glucose 
• ATP is from which general category of molecules? 
• A.Polysaccharides 
• B.Proteins 
• C.Nucleotides 
• D.Amino acids
Sample questions 
• Which of the following regulates glycolysis steps? 
• A.Phosphofructokinase 
• B.Hexose kinase 
• C.Pyruvate kinase 
• D.All of these
Sample questions 
• Which of the following is not a mechanism for altering the flux 
of metabolites through the rate-determining step of a 
pathway? 
• A. Allosteric control of the enzyme activity 
• B. Block active sites 
• C. Genetic control of the enzyme concentration 
• D. Covalent modification of the enzyme 
• Phosphofructokinase, the major flux-controlling enzyme of 
glycolysis is allosterically inhibited and activated respectively 
by 
• A.ATP and PEP 
• B.AMP and Pi 
• C.ATP and ADP 
• D.Citrate and ATP
An application of glycolysis to human medicine: 
Positron Emission Tomography 
“PET scans”
PET is a medical imaging technique. 
What’s a positron? 
It is the anti-particle of an electron. It has same mass as an electron, 
and a positive charge. 
Positrons are emitted from certain types of radioactive decay, such as 
by beta decay of 18F.
In a typical PET scan, glucose fluorodeoxyglucose (FDG) enriched in 
18F is injected into the body. 
FDG 
18F is a very unstable isotope, with half-life of 2 hours; decay is by 
positron emission. 
The positron and any nearby electron annihilate, resulting in the 
emission of 2 gamma rays in opposite directions.
It turns out that hexokinase works just fine on fluorodeoxyglucose (FDG). 
But phosphoglucose isomerase can’t cope with the fluorine atom: 
phosphohexose 
isomerase 
No reaction.
So the phosphorylated FDG gets trapped in cells. 
FDG can’t proceed with further glycolysis reactions. 
FDG can’t cross the cell membrane due to the charge on the phosphate (the 
glucose transporter won’t let it through).
In a typical PET scan, FDG enriched in 18F is 
injected. The FDG accumulates in cells 
where glycolysis is most active, and emits 
positrons. 
Positrons encounter electrons and 
annhilate, resulting in 2 gamma rays 
emitted in opposite directions. 
The location of the FDG is at 
the mid-point of where the 2 
gamma rays strike the 
detector.
Human brains concentrate FDG in their most metabolically active parts. 
PET scan image of fluorodeoxyglucose (FDG) 
distribution in an active human brain.
Most clinical PET scans are performed for cancer detection. 
Many types of cancer metabolize glucose at a highly elevated rate 
compared to normal cells. 
The hyperactive glycolysis activity of cancer cells was reported by Otto 
Warburg in 1924 (the “Warburg effect”).
Cancer and exercise affect glycolysis in a similar way 
Tumors -> enhanced uptake of glucose -> enhanced glycolysis 
Glycolysis rates are elevated up to 200 times in cancer cells, relative to 
surrounding normal cells. 
Hypoxia: O2 deficiency 
Tumor cells grow too fast -> not enough O2 for aerobic process -> anaerobic conditions (lactate)-> 
glycolysis primary source for ATP production -> induction of blood vessel growth
PET image of human body, showing 
regions where 18F fluorodeoxyglucose is 
most concentrated. 
Post-therapy image (on right) shows 
that the tumors have reduced glycolysis 
activity.

Contenu connexe

Tendances

Glycolysis , its regulation and energetics
Glycolysis , its regulation and energeticsGlycolysis , its regulation and energetics
Glycolysis , its regulation and energeticsPratikshaPuranik5
 
Gluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceGluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceNamrata Chhabra
 
Uronic acid pathway
Uronic acid pathwayUronic acid pathway
Uronic acid pathwayAshok Katta
 
Metabolism of glycogen
Metabolism of glycogenMetabolism of glycogen
Metabolism of glycogenAshok Katta
 
BIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDSBIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDSYESANNA
 
Gluconeogenesis - The Pathway and Regulation
Gluconeogenesis - The Pathway and Regulation Gluconeogenesis - The Pathway and Regulation
Gluconeogenesis - The Pathway and Regulation Arun Geetha Viswanathan
 
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)YESANNA
 
Pentose phosphate pathway
Pentose phosphate pathway Pentose phosphate pathway
Pentose phosphate pathway Rajan Kumar
 
Gluconeogenesis
Gluconeogenesis Gluconeogenesis
Gluconeogenesis Rajan Kumar
 
Fructose metabolism
Fructose metabolismFructose metabolism
Fructose metabolismrohini sane
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolismZainab&Sons
 
Gluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysisGluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysisHasnahana Chetia
 
Biological oxidation Bioenergetics and general concepts (part - I)
Biological oxidation    Bioenergetics and general concepts (part - I)Biological oxidation    Bioenergetics and general concepts (part - I)
Biological oxidation Bioenergetics and general concepts (part - I)Ashok Katta
 
BIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDESBIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDESYESANNA
 
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISMGLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISMYESANNA
 

Tendances (20)

Glycolysis , its regulation and energetics
Glycolysis , its regulation and energeticsGlycolysis , its regulation and energetics
Glycolysis , its regulation and energetics
 
Gluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceGluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significance
 
PENTOSE PHOSPHATE PATHWAY
PENTOSE PHOSPHATE PATHWAY PENTOSE PHOSPHATE PATHWAY
PENTOSE PHOSPHATE PATHWAY
 
Uronic acid pathway
Uronic acid pathwayUronic acid pathway
Uronic acid pathway
 
Metabolism of glycogen
Metabolism of glycogenMetabolism of glycogen
Metabolism of glycogen
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
BIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDSBIOSYNTHESIS OF FATTY ACIDS
BIOSYNTHESIS OF FATTY ACIDS
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Gluconeogenesis - The Pathway and Regulation
Gluconeogenesis - The Pathway and Regulation Gluconeogenesis - The Pathway and Regulation
Gluconeogenesis - The Pathway and Regulation
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolism
 
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)
PYRUVATE DEHYDROGENASE COMPLEX (PDH-MULTI-ENZYME COMPLEX)
 
Pentose phosphate pathway
Pentose phosphate pathway Pentose phosphate pathway
Pentose phosphate pathway
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Gluconeogenesis
Gluconeogenesis Gluconeogenesis
Gluconeogenesis
 
Fructose metabolism
Fructose metabolismFructose metabolism
Fructose metabolism
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolism
 
Gluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysisGluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysis
 
Biological oxidation Bioenergetics and general concepts (part - I)
Biological oxidation    Bioenergetics and general concepts (part - I)Biological oxidation    Bioenergetics and general concepts (part - I)
Biological oxidation Bioenergetics and general concepts (part - I)
 
BIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDESBIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDES
 
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISMGLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
 

Similaire à 13 Biochemistry _ Glycolysis

Similaire à 13 Biochemistry _ Glycolysis (20)

glycolysis.pdf
glycolysis.pdfglycolysis.pdf
glycolysis.pdf
 
glycolysis-ppt.pdf
glycolysis-ppt.pdfglycolysis-ppt.pdf
glycolysis-ppt.pdf
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
ASY-Glycolysis-2021.pdf
ASY-Glycolysis-2021.pdfASY-Glycolysis-2021.pdf
ASY-Glycolysis-2021.pdf
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Gluconeogenesis for medical school
Gluconeogenesis for medical schoolGluconeogenesis for medical school
Gluconeogenesis for medical school
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Glycolysis-general introduction and pathway with biochemical logic
Glycolysis-general introduction and pathway with biochemical logicGlycolysis-general introduction and pathway with biochemical logic
Glycolysis-general introduction and pathway with biochemical logic
 
Unit 2 carbohydrate metabolism
Unit 2 carbohydrate metabolismUnit 2 carbohydrate metabolism
Unit 2 carbohydrate metabolism
 
Unit 2 carbohydrate metabolism
Unit 2 carbohydrate metabolismUnit 2 carbohydrate metabolism
Unit 2 carbohydrate metabolism
 
Glycolysis (with animated pathway)
Glycolysis (with animated pathway)Glycolysis (with animated pathway)
Glycolysis (with animated pathway)
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Carbohydrate 2
Carbohydrate 2Carbohydrate 2
Carbohydrate 2
 
AN OVERVIEW OF BIOCHEMICAL PATHWAYS- SOURCE OF ALL METABOLIC FUEL
AN OVERVIEW OF BIOCHEMICAL PATHWAYS- SOURCE OF ALL METABOLIC FUELAN OVERVIEW OF BIOCHEMICAL PATHWAYS- SOURCE OF ALL METABOLIC FUEL
AN OVERVIEW OF BIOCHEMICAL PATHWAYS- SOURCE OF ALL METABOLIC FUEL
 
Carbohydrate Metabolism (Glycolysis).pptx
Carbohydrate Metabolism (Glycolysis).pptxCarbohydrate Metabolism (Glycolysis).pptx
Carbohydrate Metabolism (Glycolysis).pptx
 
Glycolysis - Glucose oxidation
Glycolysis - Glucose oxidationGlycolysis - Glucose oxidation
Glycolysis - Glucose oxidation
 
Glycolysis presentation
Glycolysis presentationGlycolysis presentation
Glycolysis presentation
 
Glycolsis
GlycolsisGlycolsis
Glycolsis
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Glycolysis And Fermentation
Glycolysis And FermentationGlycolysis And Fermentation
Glycolysis And Fermentation
 

Plus de Prabesh Raj Jamkatel

18 mycoplasm,chlmydia,rickettsia
18 mycoplasm,chlmydia,rickettsia18 mycoplasm,chlmydia,rickettsia
18 mycoplasm,chlmydia,rickettsiaPrabesh Raj Jamkatel
 
16 zoonoses [zoʊ'ɒnəsɪs] pathogens
16 zoonoses [zoʊ'ɒnəsɪs] pathogens16 zoonoses [zoʊ'ɒnəsɪs] pathogens
16 zoonoses [zoʊ'ɒnəsɪs] pathogensPrabesh Raj Jamkatel
 
7 prevetion of pathogenic microbial infection
7 prevetion of  pathogenic microbial infection7 prevetion of  pathogenic microbial infection
7 prevetion of pathogenic microbial infectionPrabesh Raj Jamkatel
 
6 laboratory diagnosis of bacterial infection
6 laboratory diagnosis  of bacterial infection6 laboratory diagnosis  of bacterial infection
6 laboratory diagnosis of bacterial infectionPrabesh Raj Jamkatel
 
5 immune defense against bacterial pathogens
5 immune defense against bacterial  pathogens5 immune defense against bacterial  pathogens
5 immune defense against bacterial pathogensPrabesh Raj Jamkatel
 
4 bacterial infection and pathogenesis
4  bacterial infection and pathogenesis4  bacterial infection and pathogenesis
4 bacterial infection and pathogenesisPrabesh Raj Jamkatel
 
3 heredity and variation of bacteria
3 heredity and variation of bacteria3 heredity and variation of bacteria
3 heredity and variation of bacteriaPrabesh Raj Jamkatel
 
0 introdution to Medical Microbiology
0  introdution to Medical Microbiology0  introdution to Medical Microbiology
0 introdution to Medical MicrobiologyPrabesh Raj Jamkatel
 

Plus de Prabesh Raj Jamkatel (20)

18 mycoplasm,chlmydia,rickettsia
18 mycoplasm,chlmydia,rickettsia18 mycoplasm,chlmydia,rickettsia
18 mycoplasm,chlmydia,rickettsia
 
17 spirochetes
17  spirochetes17  spirochetes
17 spirochetes
 
16 zoonoses pathogens
16 zoonoses pathogens16 zoonoses pathogens
16 zoonoses pathogens
 
16 zoonoses [zoʊ'ɒnəsɪs] pathogens
16 zoonoses [zoʊ'ɒnəsɪs] pathogens16 zoonoses [zoʊ'ɒnəsɪs] pathogens
16 zoonoses [zoʊ'ɒnəsɪs] pathogens
 
15 corynebacterium diphtheriae
15 corynebacterium diphtheriae15 corynebacterium diphtheriae
15 corynebacterium diphtheriae
 
14 mycobacteria
14 mycobacteria14 mycobacteria
14 mycobacteria
 
13 anaerobic bacteria
13 anaerobic bacteria13 anaerobic bacteria
13 anaerobic bacteria
 
12 campylobacter helicobacter
12 campylobacter helicobacter12 campylobacter helicobacter
12 campylobacter helicobacter
 
11 vibrios
11 vibrios11 vibrios
11 vibrios
 
10 enterobacteriaceae
10 enterobacteriaceae10 enterobacteriaceae
10 enterobacteriaceae
 
9 cocci
9 cocci9 cocci
9 cocci
 
8 drug resistance
8 drug resistance8 drug resistance
8 drug resistance
 
7 prevetion of pathogenic microbial infection
7 prevetion of  pathogenic microbial infection7 prevetion of  pathogenic microbial infection
7 prevetion of pathogenic microbial infection
 
6 laboratory diagnosis of bacterial infection
6 laboratory diagnosis  of bacterial infection6 laboratory diagnosis  of bacterial infection
6 laboratory diagnosis of bacterial infection
 
5 immune defense against bacterial pathogens
5 immune defense against bacterial  pathogens5 immune defense against bacterial  pathogens
5 immune defense against bacterial pathogens
 
4 bacterial infection and pathogenesis
4  bacterial infection and pathogenesis4  bacterial infection and pathogenesis
4 bacterial infection and pathogenesis
 
3 heredity and variation of bacteria
3 heredity and variation of bacteria3 heredity and variation of bacteria
3 heredity and variation of bacteria
 
2 biosafety
2 biosafety2 biosafety
2 biosafety
 
0 introdution to Medical Microbiology
0  introdution to Medical Microbiology0  introdution to Medical Microbiology
0 introdution to Medical Microbiology
 
1 basic characters of bacteria
1 basic characters of bacteria1 basic characters of bacteria
1 basic characters of bacteria
 

13 Biochemistry _ Glycolysis

  • 2. Catabolism Catabolism is the set of metabolic pathways that breaks down molecules into smaller units to release energy
  • 3. Central Role of Glucose Major pathways of glucose utilization
  • 4. Glycolysis – Carried out by nearly every living cell • In cytosol of eukaryotes – Catabolic process • Releases energy stored in covalent bonds – Stepwise degradation • Glucose • Other simple sugars
  • 6. Two phases of glycolysis Glucose + 6O2 = 6CO2 + 6H2O DGo= -2840 kJ/mol Glucose + 2NAD+ = 2Pyruvate + 2NADH + 2H+ DGo = -146 kJ/mol 5.2% of total free energy that can be released by glucose is released in glycolysis.
  • 7. Reaction 1: phosphorylation Phosphorylation of glucose Glycolysis takes place in the cytosol of cells. Glucose enters the Glycolysis pathway by conversion to glucose-6-phosphate. Initially there is energy input corresponding to cleavage of two ~P bonds of ATP. Kinase: An enzyme that catalyzes the phosphorylation of a molecule using ATP.
  • 8. Glycolysis - Enzyme mechanisms Pictorial analogy: water represents flux of metabolites, amount of water in flask represents amount of a particular intermediate, pipes between flasks are enzymes, vertical drop represents decrease in free energy DG˚ = height difference between flask bottoms (The change in standard Gibbs free energy, the formation of 1 mole substance) DG = height difference between water levels (The change in Gibbs free energy ) Koelle, lec15, p21
  • 9. Hexokinase catalyzes: Glucose + ATP  glucose-6-P + ADP The reaction involves nucleophilic attack of the C6 hydroxyl O of glucose on P of the terminal phosphate of ATP. ATP binds to the enzyme as a complex with Mg++. N N NH2 N N O CH2 H H H OH OH H O O O -O P O P O P O O- O- O- adenine ribose ATP adenosine triphosphate
  • 10. Induced fit: Glucose binding to Hexokinase stabilizes a conformation in which:  the C6 hydroxyl of the bound glucose is close to the terminal phosphate of ATP, promoting catalysis.  water is excluded from the active site. This prevents the enzyme from catalyzing ATP hydrolysis, rather than transfer of phosphate to glucose.
  • 11. Hexokinase reaction I. This enzyme is present in most cells. In liver Glucokinase is the main hexokinase which prefers glucose as substrate. II. It requires Mg-ATP complex as substrate. Un-complexed ATP is a potent competitive inhibitor of this enzyme. III. Enzyme catalyses the reaction by proximity effect; bringing the two substrate in close proximity. IV. This enzyme undergoes large conformational change upon binding with Glucose. It is inhibited allosterically by G6P.
  • 12. Reaction 2: isomerization Conversion of glucose 6-phosphate to fructose 6-phosphate aldose ketose Isomerase: An enzyme that catalyzes the transformation of compounds into their positional isomers. In the case of sugars this usually involves the interconversion of an aldose into a ketose, or vice versa.
  • 13. Phosphoglucose Isomerase catalyzes: glucose-6-P (aldose)  fructose-6-P (ketose) The mechanism involves acid/base catalysis. The acid/base catalysis, and is thought to proceed via an enediol intermediate, as with Phosphoglucose Isomerase. Active site Glu and His residues are thought to extract and donate protons during catalysis.
  • 15. CH2OPO3 2- Phosphofructokinase 6 1 CH2OPO3 CH2OH 2 OH 5 H O H HO 4 3 OH H 6 2- CH2OPO3 2 OH 2- 5 H O H HO 4 3 OH H 1 ATP ADP Mg2+ fructose-6-phosphate fructose-1,6-bisphosphate Phosphofructokinase catalyzes: fructose-6-P + ATP  fructose-1,6-bisP + ADP This highly spontaneous reaction has a mechanism similar to that of Hexokinase. The Phosphofructokinase reaction is the rate-limiting step of Glycolysis. The enzyme is highly regulated.
  • 16. Phosphofructokinase-1 Reaction: Transfer of phosphoryl group from ATP to C-1 of F6P to produce Fructose 1,6 bisphosphate. I. This step is an important irreversible, regulatory step. II. The enzyme Phosphofructokinase-1 is one of the most complex regulatory enzymes, with various allosteric inhibitors and activators. III. ATP is an allosteric inhibitor, and Fructose 2,6 bisphosphate is an activator of this enzyme. IV. ADP and AMP also activate PFK-1 whereas citrate is an inhibitor.
  • 18. 1CH2OPO3 2 HO 3 H H OH H OH C C C C CH2OPO3 4 5 6 2- Aldolase 2- O 3 2 1 CH2OPO3 2- C O CH2OH H O C C CH2OPO3 1 2 3 + H OH fructose-1,6- bisphosphate dihydroxyacetone glyceraldehyde-3- phosphate phosphate Triosephosphate Isomerase Aldolase catalyzes: fructose-1,6-bisphosphate  2- dihydroxyacetone-P + glyceraldehyde-3-P The reaction is an aldol cleavage, the reverse of an aldol condensation. Note that C atoms are renumbered in products of Aldolase.
  • 19. Schiff base intermediate of Aldolase reaction lysine A lysine residue at the active site functions in catalysis. The keto group of fructose-1,6-bisphosphate reacts with the e- amino group of the active site lysine, to form a protonated intermediate. Cleavage of the bond between C3 & C4 follows.
  • 20. Reaction 5: isomerization Triose Phosphate Isomerase (TIM) catalyzes: dihydroxyacetone-P  glyceraldehyde-3-P
  • 21. Triose Phosphate Isomerase (TPI) Triose phosphate isomerase (TPI) -> Isomerisation accelerated 1010-fold -> Kcat/Km = 2*108 M-1 s-1 -> kinetically perfect enzyme -> suppresses an undesired side reaction Reaction 100 times faster TPI traps enediol intermediate -> prevents side reaction -> opens again when GAP formed
  • 22. Reaction 6: oxidation Glyceraldehyde-3-phosphate Dehydrogenase catalyzes: glyceraldehyde-3-P + NAD+ + Pi  1,3-bisphosphoglycerate + NADH + H+
  • 24. Reaction 7: substrate level phosphorylation Phosphoglycerate Kinase catalyzes: 1,3-bisphosphoglycerate + ADP  3-phosphoglycerate + ATP This phosphate transfer is reversible.
  • 25. Reaction 8: shift of phosphoryl group Phosphoglycerate Mutase catalyzes: 3-phosphoglycerate  2-phosphoglycerate Mutase: An enzyme that catalyzes the transposition of functional groups, such as phosphates, sulfates, etc.
  • 26. An active site histidine side-chain participates in Pi transfer, by donating & accepting phosphate. The process involves a 2,3-bisphosphate intermediate. C C CH2OPO3 2- O O- 1 H OPO3 2- 2 3 2,3-bisphosphoglycerate
  • 27. Phosphoglycerate Mutase Reaction: Conversion of 3- phosphoglycerate to 2-phosphoglycerate (2-PG). I. In active form, the phosphoglycerate mutase is phosphorylated at His-179. II. There is transfer of the phosphoryl group from enzyme to 3-PG, generating enzyme bound 2,3-biphosphoglycerate intermediate. This compound has been observed occasionally in reaction mixture. III. In the last step of reaction the phosphoryl group from the C-3 of the intermediate is transferred to the enzyme and 2-PG is released. IV. In most cells 2,3BPG is present in trace amount, but in erythrocytes it is present in significant amount. There it regulates oxygen affinity to hemoglobin.
  • 28. Reaction 9: dehydration Enolase catalyzes: 2-phosphoglycerate  phosphoenolpyruvate + H2O This dehydration reaction is Mg++-dependent.
  • 29. Reaction 10: substrate level phosphorylation Pyruvate Kinase catalyzes: phosphoenolpyruvate + ADP  pyruvate + ATP
  • 30. glucose Glycolysis ATP ADP glucose-6-phosphate Hexokinase Phosphoglucose Isomerase fructose-6-phosphate ATP ADP fructose-1,6-bisphosphate Phosphofructokinase Aldolase glyceraldehyde-3-phosphate + dihydroxyacetone-phosphate Triosephosphate Isomerase Glycolysis continued
  • 31. glyceraldehyde-3-phosphate NAD+ + Pi NADH + H+ Glyceraldehyde-3-phosphate Dehydrogenase 1,3-bisphosphoglycerate ADP ATP 3-phosphoglycerate Phosphoglycerate Kinase Phosphoglycerate Mutase 2-phosphoglycerate H2O Enolase phosphoenolpyruvate ADP ATP Pyruvate Kinase pyruvate Glycolysis continued.
  • 32. There are 10 enzyme-catalyzed reactions in glycolysis. There are two stages Stage 1: (Reactions 1-5) A preparatory stage in which glucose is phosphorylated, converted to fructose which is again phosphorylated and cleaved into two molecules of glyceraldehyde-3-phosphate. In this phase there is an investment of two molecules of ATP. Stage 2: (Reactions 6-10) The two molecules of glyceraldehyde-3-phosphate are converted to pyruvate with the generation of four ATP molecules and two molecules of NADH. Thus there is a net gain of two ATP molecules per molecule of Glucose in glycolysis. Importance of phosphorylated intermediates: 1. Possession of negative charge which inhibit their diffusion through membrane. 2. Conservation of free energy in high energy phosphate bond. 3. Facilitation of catalysis.
  • 33. Summary of glycolysis -> 10 reaction steps -> 1 x C-6 (glucose) converted into 2x C-3 (pyruvate) -> oxidation of glucose -> 2 NADH generated -> 2 ATPs used + 4 ATPs generated -> pay off: 2 ATPs 33
  • 34. Glycolysis - total pathway, omitting H+: glucose + 2 NAD+ + 2 ADP + 2 Pi  2 pyruvate + 2 NADH + 2 ATP In aerobic organisms:  pyruvate produced in Glycolysis is oxidized to CO2 via Krebs Cycle (citric acid cycle)  NADH produced in Glycolysis & Krebs Cycle is reoxidized via the respiratory chain, with production of much additional ATP.
  • 35. Regulation of Glycolysis: Two types controls for metabolic reactions: a) Substrate limited : When concentrations of reactant and products in the cell are near equilibrium, then it is the availability of substrate which decides the rate of reaction. b) Enzyme-limited: When concentration of substrate and products are far away from the equilibrium, then it is activity of enzyme that decides the rate of reaction. Three steps in glycolysis have enzymes which regulate the flux of glycolysis. I. The hexokinase (HK) II. The phoshofructokinase (PFK) III. The pyruvate kinase
  • 36. The Glycolysis pathway is regulated by control of 3 enzymes: Hexokinase, Phosphofructokinase & Pyruvate Kinase.  Local control of metabolism involves regulatory effects of varied concentrations of pathway substrates or intermediates, to benefit the cell.  Global control is for the benefit of the whole organism, & often involves hormone-activated signal cascades. Liver cells have major roles in metabolism, including maintaining blood levels various of nutrients such as glucose. Thus global control especially involves liver
  • 37. DG < 0 B C Rate-limiting steps are regulated: reactions in the pathway that operate away from equilibrium are regulated. At these reaction steps there is a build-up of substrates because the substrates are not converted to products fast enough. Typically these reactions are regulated. DG ~ 0 C D
  • 38. Hexokinase Inhibitors Glucose 6-phosphate Phosphofructokinase Pyruvate kinase ATP CITRIC ACID CYCLE (ATP, citrate) ATP, citrate, PEP Activators ADP, AMP, Fructose 2,6P Regulation of Glycolysis
  • 40. Hexokinase Hexokinase: It is allosterically inhibited by its product Glucose 6 phosphate. In liver Glucokinase is inhibited by Fructose 6 Phosphate. Uncomplexed ATP acts as a competitive inhibitor of this enzyme. • Hexokinase reaction is metabolically irreversible • G6P (product) levels increase when glycolysis is inhibited at sites further along in the pathway Recall there are 4 isozymes • G6P inhibits hexokinase isozymes I, II and III • Glucokinase (hexokinase IV) forms G6P in the liver (for glycogen synthesis) when glucose is abundant (activity is modulated by fructose phosphates and a regulatory protein)
  • 41. Hexokinase IV (glucokinase) • Glucokinase translocates between the cytoplasm and nucleus of liver cells. • Glucose enters mammalian cells by passive transport down a concentration gradient from blood to cells • Glucose uptake into skeletal and heart muscle and adipocytes by GLUT 4 is stimulated by insulin • Other GLUT transporters mediate glucose transport in and out of cells in the absence of insulin • GLUT2 is transporter for hepatocytes • Regulator protein – inside the nucleus – Binds Hexokinase IV and inhibits it – Protein has regulatory site • Competition between glucose and fructose 6-phosphate – Glucose stimulates release of hexokinase IV into cytoplasm – Fructose 6-phosphate inhibits this process • Hexokinase IV not affected by glucose 6-phosphate as the other isozymes are
  • 42.  Glucokinase is subject to inhibition by glucokinase regulatory protein (GKRP). The ratio of Glucokinase to GKRP in liver changes in different metabolic states, providing a mechanism for modulating glucose phosphorylation.  One effect of insulin, a hormone produced when blood glucose is high, is activation in liver of transcription of the gene that encodes the Glucokinase enzyme.  Glucokinase is not subject to product inhibition by glucose-6-phosphate. Liver will take up & phosphorylate glucose even when liver [glucose-6-phosphate] is high.
  • 43. Phosphofructokinase-1 (PFK-1): It’s activity is controlled by a complex allosteric regulation. ATP is the end product of glycolysis as well as it is substrate for PFK. In presence of high concentration of ATP, ATP binds to inhibition site of PFK, and thereby decreases the activity of enzyme. (allosteric inhibitor) AMP, ADP and Fructose 2, 6 biphosphate act as allosteric activators of this enzyme. Activation of enzyme by AMP overcomes the inhibitory effect of ATP. Two other enzymatic activities are involved in the regulation of PFK. a) Adnylate kinase: It readily equilibrates 2 ADP molecules to one ATP and 1 AMP: 2ADP = ATP + AMP Any decrease in ATP and increase in ADP results in an increase in AMP concentration, which activates PFK. b) Fructose 1,6-bisphosphatase (FBPase): It catalyzes conversion of FBP to Fructose 6-phosphate, thus reverting back the PFK reaction.
  • 44.
  • 45. Regulation of Phosphofructokinase-1 • Important - this step commits glucose to glycolysis • AMP allosterically activates PFK-1 by relieving the ATP inhibition (ADP is also an activator in mammalian systems) • Changes in AMP and ADP concentrations can control the flux through PFK-1 •AMP relieves ATP inhibition of PFK-1
  • 46. Pyruvate Kinase: It is allosterically inhibited by ATP. ATP binding to the inhibitor site of pyruvate kinase decreases its ability to bind phosphoenol pyruvate (PEP) substrate. • PK is allosterically activated by Fructose 1,6 BP • PK inhibited by accumulation of alanine. • It is also inhibited by Acetyl coenzyme A and long chain fatty acid.
  • 47. Liver form – low blood sugar ®glucagon ® increased cAMP® cAMP-dependent protein kinase ® PK inactivation (is reversed by protein phosphatase)
  • 48. Transcriptional regulation of Pyruvate Kinase High [glucose] within liver cells causes a transcription factor carbohydrate responsive element binding protein (ChREBP) to be transferred into the nucleus, where it activates transcription of the gene for Pyruvate Kinase.
  • 49. Entry points for other sugars into glycolysis Uridine diphosphate galactose Galactose toxic if transferase is missing  All carbohydrates enter glycolysis  In muscle, often via hexokinase
  • 50. Case Study A 9-month-old has recurrent bouts of sweating and vomiting. Symptoms began shortly after weaning and introduction to solid foods. Testing reveals hypoglycemia and lactic acidosis after consumption of milk formula or fruit. Enzyme activity testing reveals a deficiency in fructose 1- phosphate aldolase. Notably, her 3-year-old brother has a marked aversion to fruit.
  • 51. Fructose intolerance Hereditary fructose intolerance results from a defect in fructose breakdown in the liver, usually in aldolase.
  • 52. Galactosemia Galatosemia results from a defect in galactose breakdown. Defects in GALK (galactokinase), GALT (transferase), or GALE (epimerase) all cause galatosemia.
  • 53. Fate of the products, pyruvate and NADH Fig 14- 3
  • 55. Lactate Dehydrogenase O- C C CH3 O O O- C HC CH3 OH O NADH + H+ NAD+ pyruvate lactate Lactate Dehydrogenase catalyzes reduction of the keto in pyruvate to a hydroxyl, yielding lactate, as NADH is oxidized to NAD+. Skeletal muscles ferment glucose to lactate during exercise, when the exertion is brief and intense. Lactate released to the blood may be taken up by other tissues, or by skeletal muscle after exercise, and converted via Lactate Dehydrogenase back to pyruvate, which may be oxidized in Krebs Cycle or (in liver) converted to back to glucose via gluconeogenesis
  • 56. Cell membranes contain carrier proteins that facilitate transport of lactate. Lactate serves as a fuel source for cardiac muscle as well as brain neurons. Astrocytes, which surround and protect neurons in the brain, ferment glucose to lactate and release it. Lactate taken up by adjacent neurons is converted to pyruvate that is oxidized via Krebs Cycle.
  • 58. Pyruvate Alcohol Decarboxylase Dehydrogenase O- C C CH3 O O NADH + H+ NAD+ H O H C OH CH3 C CH3 H CO2 pyruvate acetaldehyde ethanol Some anaerobic organisms metabolize pyruvate to ethanol, which is excreted as a waste product. NADH is converted to NAD+ in the reaction catalyzed by Alcohol Dehydrogenase.
  • 59. Glycolysis, omitting H+: glucose + 2 NAD+ + 2 ADP + 2 Pi  2 pyruvate + 2 NADH + 2 ATP Fermentation, from glucose to lactate: glucose + 2 ADP + 2 Pi  2 lactate + 2 ATP
  • 60. Regulation of glycolysis Irreversible steps are regulated: Hexokinase/Glucokinase Phosphofructokinase I Pyruvate Kinase
  • 61. Regulation of glycolysis in the muscle -> ATP based regulation ATP inhibits all 3 enzymes Need for ATP (high AMP) activates PFK 61
  • 62. NADPH is necessary to protect against reactive oxygen species Ribose 5-P is necessary in rapidly dividing cells Glucose 6-P + 2 NADP+ + H2O  Ribose 5-P + 2 NADPH + 2 H+ + CO2
  • 63. Regulation G6P dehydrogenase is allosterically inhibited by NADPH; activated by NADP+
  • 64. Sample questions • Glycolytic pathway regulation involves • A. allosteric stimulation by ADP • B. allosteric inhibition by ATP • C. feedback, or product, inhibition by ATP • D. all of the above • Why does the glycolytic pathway continue in the direction of glucose catabolism? • A. There are essentially three irreversible reactions that act as the driving force for the pathway • B. High levels of ATP keep the pathway going in a forward direction • C. The enzymes of glycolysis only function in one direction • D. Glycolysis occurs in either direction
  • 65. Sample questions The released energy obtained by oxidation of glucose is stored as A. a concentration gradient across a membrane B. ADP C. ATP D. NAD+ A kinase is an enzyme that A. removes phosphate groups of substrates B. uses ATP to add a phosphate group to the substrate C. uses NADH to change the oxidation state of the substrate D. removes water from a double bond
  • 66. Sample questions • For every one molecule of sugar glucose which is oxidized __________ molecule of pyruvic acid are produced. • A.1 • B.2 • C.3 • D.4 • The enzymes of glycolysis in a eukaryotic cell are located in the • A.intermembrane space • B.plasma membrane • C.cytosol • D.mitochondrial matrix
  • 67. Sample questions • Which of the following is not true of glycolysis? • A.ADP is phosphorylated to ATP via substrate level phosphorylation • B.The pathway does not require oxygen • C.The pathway oxidizes two moles of NADH to NAD+ for each mole of glucose that enters • D.The pathway requires two moles of ATP to get started catabolizing each mole of glucose • ATP is from which general category of molecules? • A.Polysaccharides • B.Proteins • C.Nucleotides • D.Amino acids
  • 68. Sample questions • Which of the following regulates glycolysis steps? • A.Phosphofructokinase • B.Hexose kinase • C.Pyruvate kinase • D.All of these
  • 69. Sample questions • Which of the following is not a mechanism for altering the flux of metabolites through the rate-determining step of a pathway? • A. Allosteric control of the enzyme activity • B. Block active sites • C. Genetic control of the enzyme concentration • D. Covalent modification of the enzyme • Phosphofructokinase, the major flux-controlling enzyme of glycolysis is allosterically inhibited and activated respectively by • A.ATP and PEP • B.AMP and Pi • C.ATP and ADP • D.Citrate and ATP
  • 70. An application of glycolysis to human medicine: Positron Emission Tomography “PET scans”
  • 71. PET is a medical imaging technique. What’s a positron? It is the anti-particle of an electron. It has same mass as an electron, and a positive charge. Positrons are emitted from certain types of radioactive decay, such as by beta decay of 18F.
  • 72. In a typical PET scan, glucose fluorodeoxyglucose (FDG) enriched in 18F is injected into the body. FDG 18F is a very unstable isotope, with half-life of 2 hours; decay is by positron emission. The positron and any nearby electron annihilate, resulting in the emission of 2 gamma rays in opposite directions.
  • 73. It turns out that hexokinase works just fine on fluorodeoxyglucose (FDG). But phosphoglucose isomerase can’t cope with the fluorine atom: phosphohexose isomerase No reaction.
  • 74. So the phosphorylated FDG gets trapped in cells. FDG can’t proceed with further glycolysis reactions. FDG can’t cross the cell membrane due to the charge on the phosphate (the glucose transporter won’t let it through).
  • 75. In a typical PET scan, FDG enriched in 18F is injected. The FDG accumulates in cells where glycolysis is most active, and emits positrons. Positrons encounter electrons and annhilate, resulting in 2 gamma rays emitted in opposite directions. The location of the FDG is at the mid-point of where the 2 gamma rays strike the detector.
  • 76. Human brains concentrate FDG in their most metabolically active parts. PET scan image of fluorodeoxyglucose (FDG) distribution in an active human brain.
  • 77. Most clinical PET scans are performed for cancer detection. Many types of cancer metabolize glucose at a highly elevated rate compared to normal cells. The hyperactive glycolysis activity of cancer cells was reported by Otto Warburg in 1924 (the “Warburg effect”).
  • 78. Cancer and exercise affect glycolysis in a similar way Tumors -> enhanced uptake of glucose -> enhanced glycolysis Glycolysis rates are elevated up to 200 times in cancer cells, relative to surrounding normal cells. Hypoxia: O2 deficiency Tumor cells grow too fast -> not enough O2 for aerobic process -> anaerobic conditions (lactate)-> glycolysis primary source for ATP production -> induction of blood vessel growth
  • 79. PET image of human body, showing regions where 18F fluorodeoxyglucose is most concentrated. Post-therapy image (on right) shows that the tumors have reduced glycolysis activity.